Supplemental Table from Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer

Autor: Federico Innocenti, Gianna Tabaro, Gianmaria Miolo, Blase N. Polite, Angela Buonadonna, Quan Mai, Elizabeth Gray, Bianca Posocco, Elena Marangon, Manish R. Sharma, Giuseppe Toffoli
Rok vydání: 2023
Popis: Supplementary Table 1. Toxicities during the first cycle of FOLFIRI plus bevacizumab. Number of patients (%) is indicated. Toxicities were included if they occurred in at least 10% of patients or if they were grade 3 or greater, and if they were at least possibly related to treatment.
Databáze: OpenAIRE